Glenview Trust’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.26M | Buy |
30,381
+28
| +0.1% | +$3.01K | 0.06% | 184 |
|
|
2025
Q1 | $3.06M | Buy |
30,353
+269
| +0.9% | +$27.1K | 0.06% | 177 |
|
|
2024
Q4 | $2.69M | Sell |
30,084
-1,001
| -3% | -$89.4K | 0.05% | 186 |
|
|
2024
Q3 | $2.6M | Sell |
31,085
-107
| -0.3% | -$8.97K | 0.05% | 188 |
|
|
2024
Q2 | $2.4M | Buy |
31,192
+1,541
| +5% | +$119K | 0.05% | 185 |
|
|
2024
Q1 | $2.03M | Buy |
29,651
+38
| +0.1% | +$2.6K | 0.04% | 202 |
|
|
2023
Q4 | $1.71M | Buy |
29,613
+127
| +0.4% | +$7.34K | 0.04% | 206 |
|
|
2023
Q3 | $1.56M | Buy |
29,486
+54
| +0.2% | +$2.85K | 0.04% | 197 |
|
|
2023
Q2 | $1.59M | Sell |
29,432
-1,438
| -5% | -$77.8K | 0.04% | 186 |
|
|
2023
Q1 | $1.54M | Buy |
30,870
+39
| +0.1% | +$1.95K | 0.05% | 186 |
|
|
2022
Q4 | $1.43M | Buy |
30,831
+9,987
| +48% | +$462K | 0.05% | 190 |
|
|
2022
Q3 | $807K | Buy |
20,844
+7,846
| +60% | +$304K | 0.03% | 219 |
|
|
2022
Q2 | $484K | Buy |
12,998
+65
| +0.5% | +$2.42K | 0.02% | 284 |
|
|
2022
Q1 | $573K | Buy |
+12,933
| New | +$573K | 0.02% | 276 |
|
|
2021
Q4 | – | Sell |
-4,680
| Closed | -$203K | – | 419 |
|
|
2021
Q3 | $203K | Hold |
4,680
| – | – | 0.01% | 395 |
|
|
2021
Q2 | $200K | Buy |
+4,680
| New | +$200K | 0.01% | 403 |
|
|
2014
Q4 | $195K | Buy |
+14,697
| New | +$195K | 0.02% | 224 |
|